MR
Moderna
MRNA · NASDAQ
$145.55 -4.87% (-$7.45)
1M +145.99%
Market Cap $59.1B
P/E Ratio -
Div. Yield -
ROE 39.21%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 8.74x
P/S 26.51x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 23.24%
Rev. growth 53.13%
FCF growth N/A
Profitability
0 /100
Weak Net margin 141.43%
Op. margin 149.01%
FCF margin 54.89%
Quality
3 /100
Poor ROE 39.21%
ROA 28.75%
Asset turnover 0.20x
Debt
69 /100
Low Current ratio 2.29x
Int. coverage -122.80x
Debt/Equity 0.19x
Stability
50 /100
Moderate Rev. volatility 12.29%
EPS volatility 106.63%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MRNA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stéphane Bancel
Employees
4,700
Headquarters
Cambridge
Upcoming events
05 NOV
Earnings
Upcoming earnings report